Last Updated On 3/8/2025 2:17:18 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Lilly |
Recipient: You |
Company: Immune Design |
Recipient: You |
Company: Merck Serono |
Recipient: You |
Company: Adaptimmune |
Recipient: You |
Company: Daiichi Sankyo |
Recipient: You |
Company: Eisai |
Recipient: You |
Company: Morphotek |
Recipient: You |
Company: TRACON Pharma |
Recipient: You |
Company: Immodulon Therapeutics |
Recipient: You |
Company: Deciphera |
Recipient: You |
Company: PharmaMar |
Recipient: You |
Company: Blueprint Medicines |
Recipient: You |
Company: Clinigen Group |
Recipient: You |
Company: Epizyme |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: Karma Oncology |
Recipient: You |
Company: UpToDate |
Recipient: You |
Company: Athenex |
Recipient: You |
Company: Immunicum |
Recipient: You |
Company: Mundipharma |
Recipient: You |
Company: Springworks |
Recipient: You |
Company: SynOX |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: GlaxoSmithKline |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: PharmaMar |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|